T2D - managing CVD risk factors

Rinki Murphy outlines the practical strategies GPs can put in place to enable systematic CVD risk factor management among patients with T2D.

Topics

Intro
Play now
What percentage does CVD risk increase by for the T2D patient?
Play now
What is the underlying mechanism at play here?
Play now
Helping to mitigate this risk?
Play now
Universal screening - how often?
Play now
SGLT2i/GLP1RA - What is the data supporting their use?
Play now
Is the trial data correct?
Play now
CVD risk reduction - which class is most beneficial?
Play now
Monitoring – what to be aware of?
Play now
Sick day management – criteria for stopping and starting?
Play now
Take-home messages
Play now

Take home messages

Not all patients with T2D have the same high level of CVD risk.
Use the updated CVD risk prediction tool.
Use either SGLT2i or the GLP1RA early in T2D patients with CVD risk above 15%
Blood pressure reduction (ABCD memory aid)
Patient education a support is key.

Patient Resources

Presenter

Rinki Murphy

Diabetes Physician

Rinki is a Diabetes Physician at Auckland DHB and Counties Manukau Health. Rinki is an Associate Professor in Medicine at the University of Auckland and Principle investigator at the Maurice Wilkins Centre for Biodiscovery. She is a diabetologist at Auckland and Counties Manukau DHB.